Research news
A prognostic parameter in the response to infliximab
The response to infliximab in patients with Crohn's disease (CD) is mediated by interleukin-15 (IL-15) and its soluble receptor.
IBD and risk of colorectal cancer
It is well known that IBD constitutes a risk factor in the development of colorectal cancer, but this risk differs between men and women.
Role of mucins in parasitic infections of the intestine
The mucus barrier is an integral part of the mucosal immune system of the intestinal epithelium.
Search for susceptibility genes in primary sclerosing cholangitis
In humans, genetic studies and the search for susceptibility genes are of utmost importance
The overlooked of Intestinal Flora !
International workshop organized by DigestScience next June 4th, 2010 in Lille.
Therapeutic hope for UC
Rosiglitazone enemas can improve ulcerative colitis (UC) by restoring peroxisome proliferator-activated receptor-gamma activity.